Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07413172 · ClinicalTrials.gov registry record · Phase 2
Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye
A Phase 2 study, sponsored by University of Miami.
- Not yet
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT07413172 is a Phase 2 study that has not yet begun recruiting, run by University of Miami. The registered enrollment target is 20 participants.
The verdict
NCT07413172, a Phase 2 study, has not yet begun recruiting, sponsored by University of Miami.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study aims to find out whether adding sodium hyaluronate, a moisturizing ingredient commonly found in artificial tears, makes autologous serum eye drops more effective for treating moderate-to-severe dry eye disease. Each participant will use one version of the drops in one eye and the standard version in the other eye. The goal is to see if the new combination provides better relief, comfort, and eye surface healing compared to the traditional formulation.
Interventions
- BIOLOGICAL Autologous Serum Tears (50% Autologous Serum Tears + 0.2% Sodium Hyaluronate)
- BIOLOGICAL Biological - Autologous Serum Tears (50% Autologous Serum Tears + Balanced Saline Solution (BSS)
- OTHER Standard of Care (SOC) Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07413172
The ClinicalTrials.gov registry entry for NCT07413172 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Autologous Serum Tears (50% Autologous Serum Tears + 0.2% Sodium Hyaluronate) is the first listed.
NCT07413172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07413172 about?
NCT07413172 is a clinical study titled "Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye". This study aims to find out whether adding sodium hyaluronate, a moisturizing ingredient commonly found in artificial tears, makes autologous serum eye drops more effective for treating moderate-to-severe dry eye disease. Each participant will use one version of the drops in one eye and the standard...
What is the current status of trial NCT07413172?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2026-07. Estimated completion is 2028-07.
What interventions are being tested in trial NCT07413172?
The interventions under investigation include: Autologous Serum Tears (50% Autologous Serum Tears + 0.2% Sodium Hyaluronate) (BIOLOGICAL), Biological - Autologous Serum Tears (50% Autologous Serum Tears + Balanced Saline Solution (BSS) (BIOLOGICAL), Standard of Care (SOC) Treatment (OTHER).
Who is sponsoring clinical trial NCT07413172?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.